Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia

References

• NNIS SystemNational Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued Aug 2003Am J Infect Control20033148149814647111
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; Infectious Diseases Society of AmericaGuidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumoniaAm J Respir Crit Care Med200517138841615699079
   PubMed Web of Science ®Google Scholar
• ChastreJFagonJYVentilator-associated pneumoniaAm J Respir Crit Care Med200216586790311934711
   PubMed Web of Science ®Google Scholar
• DiekemaDJPfallerMASchmitzFJSENTRY Participants GroupSurvey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clin Infect Dis200115S114S13211320452
   PubMed Web of Science ®Google Scholar
• KollefMHShorrATabakYPGuptaVLiuLZJohannesRSEpidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumoniaChest20051283854386216354854
   PubMed Web of Science ®Google Scholar
• OsmonSWardSFraserVJKollefMHHospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosaChest200412560761614769745
   PubMed Web of Science ®Google Scholar
• ChungDRSongJHKimSHAsian Network for Surveillance of Resistant Pathogens Study GroupHigh prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in AsiaAm J Respir Crit Care Med20111841409141721920919
   PubMed Web of Science ®Google Scholar
• UcgunIDagliCEKiremitciAYildirimHAkGAslanSEffects of isolation rooms on the prevalence of hospital acquired pneumonia in a respiratory ICUEur Rev Med Pharmacol Sci201312823436659
   PubMed Web of Science ®Google Scholar
• TacconelliEDe AngelisGPneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and managementCurr Opin Pulm Med20091521822219373090
   PubMed Web of Science ®Google Scholar
• MartinJHNorrisRBarrasMTherapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases PharmacistsClin Biochem Rev201031212420179794
   PubMedGoogle Scholar
• RybakMJThe pharmacokinetic and pharmacodynamic properties of vancomycinClin Infect Dis200642Suppl 1S35S3916323118
   PubMed Web of Science ®Google Scholar
• Moise-BroderPAForrestABirminghamMCSchentagJJPharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infectionsClin Pharmacokinet20044392594215509186
   PubMed Web of Science ®Google Scholar
• JeffresMNIsakowWDohertyJAPredictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indicesChest200613094795517035423
   PubMed Web of Science ®Google Scholar
• FeelyJCoakleyDAltered pharmacodynamics in the elderlyClin Geriatr Med199062692832184923
   PubMedGoogle Scholar
• LiuGGChristensenDBThe continuing challenge of inappropriate prescribing in the elderly: an update of the evidenceJ Am Pharm Assoc200242847857
   Google Scholar
• HanlonJTSchmaderKEKoronkowskiMJAdverse drug events in high risk older outpatientsJ Am Geriatr Soc1997459459489256846
   PubMed Web of Science ®Google Scholar
• CorsonelloAPedoneCIncalziRAAge-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactionsCurr Med Chem20101757158420015034
   PubMed Web of Science ®Google Scholar
• SekiMWatanabeAMikasaKKadotaJKohnoSRevision of the severity rating and classification of hospital-acquired pneumonia in the Japanese Respiratory Society guidelinesRespirology20081388088518657061
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute2008M100-S18. Performance standards for antimicrobial susceptibility testing, 18th informational supplementClinical and Laboratory Standards InstituteWayne, PA
   Google Scholar
• KızılarslanoğluMCSancakBYağcıSHasçelikGUnalSEvaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten yearsMikrobiyol Bul201347199210 Turkish23621720
   PubMed Web of Science ®Google Scholar
• CastilloJSLealALCortesJAMortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia: a multicenter cohort study in ColombiaRev Panam Salud Publica20123234335023338691
   PubMed Web of Science ®Google Scholar
• ChenLYChenLKChangCWTreatment of community-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a hospital-based studyArch Gerontol Geriatr20125515215621820190
   PubMed Web of Science ®Google Scholar
• SakoulasGMoise-BroderPASchentagJForrestAMoelleringRCJrEliopoulosGMRelationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaJ Clin Microbiol2004422398240215184410
   PubMed Web of Science ®Google Scholar
• HidayatLKHsuDIQuistRShrinerKAWong-BeringerAHigh-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicityArch Intern Med20061662138214417060545
   PubMed Web of Science ®Google Scholar
• LodiseTPGravesJEvansARelationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycinAntimicrob Agents Chemother2008523315332018591266
   PubMed Web of Science ®Google Scholar
• KutiJLKifferCRMendesCMNicolauDPPharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in BrazilClin Microbiol Infect20081411612318076672
   PubMed Web of Science ®Google Scholar
• MohrJFMurrayBEPoint: vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureusClin Infect Dis2007441536154217516395
   PubMed Web of Science ®Google Scholar